SCHEMBL293416

SCHEMBL293416

CC1(C)CN(c2cc(Cl)ccc2Cl)C(=O)CN1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
SLC6A2 P23975 3/20 0.39
SLC6A4 P31645 3/20 0.39
SLC6A3 Q01959 3/20 0.39
ADRA1B P35368 3/20 0.39
HTR1A P08908 2/20 0.39
OPRM1 P35372 1/20 0.38
ALDH1A1 P00352 3/20 0.38
MCOLN3 Q8TDD5 2/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
ALOX12 P18054 1/20 0.38
HSD11B1 P28845 1/20 0.37
NOTUM Q6P988 2/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
USP2 O75604 1/20 0.35
HTT P42858 1/20 0.35
OPRK1 P41145 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL292093 0.87 AR (0.41) MAPTSLC6A2SLC6A4SLC6A3ADRA1B
SCHEMBL292465 0.84 FFAR4 (0.39) SLC6A2SLC6A4SLC6A3ALDH1A1KMT2A
SCHEMBL292191 0.84 HTR3E (0.46) ADRA1BALDH1A1KMT2AMEN1MAPK1
SCHEMBL292679 0.82 HSD11B1 (0.46) MAPTHTR1AOPRM1ALDH1A1HSD11B1
SCHEMBL291532 0.78 KMT2A (0.50) MAPTSLC6A2SLC6A4SLC6A3HTR1A
SCHEMBL292188 0.78 P2RX7 (0.43) SLC6A2SLC6A4SLC6A3KMT2AMEN1
SCHEMBL291498 0.74 AR (0.42) ADRA1BHTR1AOPRM1KMT2AMEN1
SCHEMBL292438 0.72 HSD17B10 (0.57) MAPTADRA1BHTR1AOPRM1ALDH1A1
SCHEMBL31537000 0.72 SLC6A4 (0.51) MAPTSLC6A2SLC6A4SLC6A3ADRA1B
SCHEMBL292608 0.71 AR (0.39) ADRA1BHTR1AOPRM1ALDH1A1HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 MAPT 4585/4885SLC6A2 411/4885SLC6A4 834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.